News for hackers. Stuff that matters.
Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by aesthesia on Sunday August 07, 2022 @08:20PM (#32381251)
In mice, of course. What are the broader implications of this supposed to be?
Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by alwillis on Sunday August 07, 2022 @10:21PM (#32381864)
One possibly obvious one:

Fasting in mice turns on SIRT3 which requires NAD+ and this newly discovered gene SLC25A51 is involved in transporting NAD+ to SIRT3. There's plenty of data that shows mice can live 30% longer when calorie-restricted due to sirtuins being activated..

Anyone who's ever listed to Dr. David Sinclair speak about longevity, he almost always talks about how NAD+ is possibly the most important chemical in the human body, since we'd be "dead in 30 seconds" without it.

Sirtuins are the longevity genes that are activated when organisms are under duress, which can be simulated by fasting. Your body doesn't know when you're going to eat again, so the sirtuins get activated.

I wouldn't be surprised if researchers and labs are looking for ways to activate SLC25A51 chemically to get the NAD+ flowing to SIRT3 without requiring fasting.

You can listen to David Sinclair and Rhonda Patrick get into the details of how all of this works: https://www.foundmyfitness.com/episodes/david-sinclair

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by TedDoesntTalk on Sunday August 07, 2022 @11:39PM (#32382205)
Rhonda Patrick is amazing. Been a subscriber to her posts podcast for 3 years. But she has tons of free content on YouTube and elsewhere.

It was disappointing to hear David Sinclair makes his own resveratrol… can’t get it

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by rsync on Monday August 08, 2022 @07:42AM (#32384367)
"I wouldn't be surprised if researchers and labs are looking for ways to activate SLC25A51 chemically to get the NAD+ flowing to SIRT3 without requiring fasting."

To what end ?

Fasting would be cheaper, easier and less time-consuming and would include all of the related, broad-spectrum effects that we also believe fasting may produce.

I guess if you're a pharma investor or existing, entrenched player it makes sense to go that direction.

As a consumer, however, I wonder why (pills that might convey a subset of the benefits of fasting) would be interesting in any way.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by TedDoesntTalk on Monday August 08, 2022 @03:43PM (#32390107)
> As a consumer, however, I wonder why

Because fasting is hard?

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by ChrstnBonanno on Sunday August 07, 2022 @10:41PM (#32381964)
Polymorphisms in SLC25A51 might be linked to chronic fatigue or other mitochondria disorders. So that is pretty important.

Sinclair, IMHO, is all protein and zero enzyme and that is his problem. Without enough zinc NMNAT will not function and will slow the SIRT cycle. And increasing SIRT activity by shoving NAD in the cell with out zinc will end up depleting zinc.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by thornjm on Sunday August 07, 2022 @08:24PM (#32381269)
Fatty liver and high fat in blood is a disease and a risk factor for serious disease respectively.

This study appears to show that fasting is related to inducing the gene Slc25a51 and improving those factors.

I guess this contributes to the body of science around the potential health benefits of fasting.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by mistrial9 on Sunday August 07, 2022 @08:39PM (#32381335)
ok - but the purpose of publicly identifying by name, a particular genetic component, is to own that function commercially somehow - am i wrong?
Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by SargeZT on Sunday August 07, 2022 @08:48PM (#32381372)
Eventually it may be a contributor to a commercialization, but now it makes it a target for research for others. This isn't patenting anything, it's scientists saying 'this is an important bit when it comes to the effects of fasting so let's focus on this.'

What would be scummy would be some pharmaceutical company discovering this, not releasing the information, and trying to develop (or worse, failing to develop) a drug on their own after internal research that was never released to the world.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by caeril on Monday August 08, 2022 @09:15AM (#32384995)
Why does this tired argument always appear on HN?

We share 97% of our genes with mice. Our organ systems and metabolic pathways are extremely similar. Our homeostatic mechanisms are nearly identical.

Some mouse models don't carry over to us, to be sure. But the reality is that most do. Do we know for a fact that this paper applies to us? No. But it significantly updates our priors. And that's always noteworthy.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by d0mine on Tuesday August 09, 2022 @07:22AM (#32396399)
9 out 10 results in mice do not transfer to humans.

For example, fasting for several hours in mice and in humans are completely different things (a human would have to fast for days to get similar results).

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by aydyn on Sunday August 07, 2022 @09:41PM (#32381672)
Mice are physiologically small humans with tails and fur. Findings in mice are very relevant to humans.
Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by Symmetry on Monday August 08, 2022 @06:36AM (#32384011)
For many things yes. But humans have been under much more intense selective pressure for longer lifespans so easy interventions along those lines that work in mice have a history of not panning out in humans.
Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by jjallen on Monday August 08, 2022 @02:21AM (#32382839)
I’ve always wondered what percentage of mice (and other non human animal) findings turned out to be applicable to humans as well.

Anyone have an idea?

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by tsol on Monday August 08, 2022 @03:13AM (#32383070)
>The first thing to note is of those drugs which pass animal tests, 94% will fail during human clinical trials stages (Phases 1 – 3)*.

https://www.understandinganimalresearch.org.uk/news/nine-out...

But to be fair, there's a huge failure rate for pharmaceutical drugs in general.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by throwawaymaths on Monday August 08, 2022 @02:56AM (#32382997)
Not confident on diabetes. The biophysical dynamics of insulin are super different in mice - they have two, one of which is missing a highly conserved amino acid across all vertebrates that is at the hinge of the critical structural element of insulin.

https://www.frontiersin.org/articles/10.3389/fendo.2021.6492... Literally no one talks about this in mice metabolic research. I would not be surprised if a huge majority of mouse researchers in diabetes are unaware.

Re:The mitochondrial NAD+ transporter SLC25A51 is a fasting-... by mnw21cam on Monday August 08, 2022 @06:21AM (#32383935)
I work in human diabetes genetics. We're just publishing work on a gene that doesn't even exist in mice - https://www.medrxiv.org/content/10.1101/2021.08.23.21262262v...

Part of our message is basically what you just said. We have multiple examples of genes where mutations cause diabetes in humans but don't in mice.

The other one we have is the fact that human pancreatic beta cell lines in labs don't even 100% act like human pancreatic beta cells in humans.